CA2132944C - Nerve stimulation apparatus and method - Google Patents
Nerve stimulation apparatus and method Download PDFInfo
- Publication number
- CA2132944C CA2132944C CA002132944A CA2132944A CA2132944C CA 2132944 C CA2132944 C CA 2132944C CA 002132944 A CA002132944 A CA 002132944A CA 2132944 A CA2132944 A CA 2132944A CA 2132944 C CA2132944 C CA 2132944C
- Authority
- CA
- Canada
- Prior art keywords
- waveform
- current
- pulse
- output
- voltage source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
Abstract
A nerve stimulation apparatus includes a waveform generator capable of generating a wave form comprising a sequence of pulses, and a controller.
The pulses have parameters as follows, a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, a pulse decay which is exponential, an amplitude of between 40 to 60 volts with a negative DC off set, and an output current of 0.01 to 10 ma.
The controller controllably varies the parameters of the pulse generator. A method of controlling pain in a human subject includes applying the waveform to the human subject.
The pulses have parameters as follows, a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, a pulse decay which is exponential, an amplitude of between 40 to 60 volts with a negative DC off set, and an output current of 0.01 to 10 ma.
The controller controllably varies the parameters of the pulse generator. A method of controlling pain in a human subject includes applying the waveform to the human subject.
Description
NERVE STIMULATION APPARATUS AND METHOD
This invention relates to a nerve stimulation apparatus and method. It relates in particular to a nerve stimulation apparatus and a method of controlling pain in a human subject.
According to the invention there is provided a nerve stimulator apparatus which includes a waveform generator for generating a waveform comprising a sequence of pulses which are operatively fed to a first output terminal and a second output terminal of the apparatus, the waveform generator comprising:
1 o current regulating means connected to the first output terminal and operable to regulate an output current of the waveform generator;
a voltage source connected to the second output terminal so that a load connectable to the first and second output terminals provides a series connection between the current regulating means and the voltage source;
a passive component connected across the first and the second output terminals to provide an exponential decay of each pulse; and a controller connected to the current regulating means and to the voltage source, said controller being operable to control the current regulating means and the voltage source so that the pulses generated by the waveform generator have a 2o repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, an amplitude of between 40 and 60 Volts, and an average output current of 0.01 to 10 mA.
The voltage source may have voltage off set means operable to adjust DC off set of the waveform so that each pulse has a positive peak of 10 to 600 mV.
The controller may include signal generating means for generating a current control signal, the current regulating means being responsive to the current control signal thereby to vary the output current from the waveform generator.
The voltage source may include a switching circuit which comprises a high frequency oscillator for generating a high frequency output signal;
a coil connected to an output of the high frequency oscillator and to which the high frequency output signal is applied in use; and rectifier means connected to the coil and arranged to rectify the high frequency output signal to provide a rectified output voltage at an output of the voltage source.
The voltage source may further include a feedback circuit operable to increase the frequency of the high frequency oscillator upon a decrease in an RMS value of the rectified output voltage of the voltage source thereby to maintain a constant rectified output voltage at the output of the voltage source.
The controller may include a microprocessor having software for controlling the waveform generator. The controller may also include a frequency to voltage converter connected to the microprocessor and operable to convert a frequency dependent signal, which is sourced from the microprocessor and representative of a desired output current, to a voltage dependent signal which is fed into the waveform generator thereby to control the output current of the waveform generator. The controller may include frequency selection means whereby the repetition rate of the waveform may be selected. The frequency selection means may be by means of links or switches hardwired to the controller. The frequency selection means may also operate in conjunction with software programmed into the controller.
The controller may include timing means operable to interrupt application of the waveform after a preselected time period. The timing means may have selection means for selecting the time period. When the controller is a microprocessor based controller the timing means ma~~ be implemented by software programmed into the controller.
The apparatus may include input mans, e.g. in the form of a keypad connected to the controller, for inputting data into the controller, e.g. to select the time period provided by the timing means, a desired current level, and so on.
The apparatus may include display means for displaying magnitude of the output current of the waveform. During operation, the timing means may also be arranged to display the duration of operation of the apparatus via the display means .
The invention extends also to the use of a generated waveform comprising a sequence of pulses having a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, and an average output current of 0.1 to 10 ma, for controlling pain, said use comprising maintaining the pulse temporarily constant at said amplitude and feeding the pulse via a passive component so that the waveform thereafter decays exponentially from the temporary constant amplitude through zero volts to a negative value and remains negative for a sufficient time period to provide a negative DC offset to the waveform.
An embodiment of the invention is now described, by way of example, with reference to the accompanying diagrammatic drawings.
In the drawing, Figure 1 shows a schematic block diagram of a nerve stimulation apparatus in accordance with the invention;
Figure 2 shows a front elevation of a control panel of the apparatus of Figure 1;
Figure 3 shows a schematic circuit diagram of a display unit used in the apparatus of Figure 1;
Figure 4 shows a time domain representation of the waveform generated by the app~~ratus of Figure 1 (which is not to scale);
This invention relates to a nerve stimulation apparatus and method. It relates in particular to a nerve stimulation apparatus and a method of controlling pain in a human subject.
According to the invention there is provided a nerve stimulator apparatus which includes a waveform generator for generating a waveform comprising a sequence of pulses which are operatively fed to a first output terminal and a second output terminal of the apparatus, the waveform generator comprising:
1 o current regulating means connected to the first output terminal and operable to regulate an output current of the waveform generator;
a voltage source connected to the second output terminal so that a load connectable to the first and second output terminals provides a series connection between the current regulating means and the voltage source;
a passive component connected across the first and the second output terminals to provide an exponential decay of each pulse; and a controller connected to the current regulating means and to the voltage source, said controller being operable to control the current regulating means and the voltage source so that the pulses generated by the waveform generator have a 2o repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, an amplitude of between 40 and 60 Volts, and an average output current of 0.01 to 10 mA.
The voltage source may have voltage off set means operable to adjust DC off set of the waveform so that each pulse has a positive peak of 10 to 600 mV.
The controller may include signal generating means for generating a current control signal, the current regulating means being responsive to the current control signal thereby to vary the output current from the waveform generator.
The voltage source may include a switching circuit which comprises a high frequency oscillator for generating a high frequency output signal;
a coil connected to an output of the high frequency oscillator and to which the high frequency output signal is applied in use; and rectifier means connected to the coil and arranged to rectify the high frequency output signal to provide a rectified output voltage at an output of the voltage source.
The voltage source may further include a feedback circuit operable to increase the frequency of the high frequency oscillator upon a decrease in an RMS value of the rectified output voltage of the voltage source thereby to maintain a constant rectified output voltage at the output of the voltage source.
The controller may include a microprocessor having software for controlling the waveform generator. The controller may also include a frequency to voltage converter connected to the microprocessor and operable to convert a frequency dependent signal, which is sourced from the microprocessor and representative of a desired output current, to a voltage dependent signal which is fed into the waveform generator thereby to control the output current of the waveform generator. The controller may include frequency selection means whereby the repetition rate of the waveform may be selected. The frequency selection means may be by means of links or switches hardwired to the controller. The frequency selection means may also operate in conjunction with software programmed into the controller.
The controller may include timing means operable to interrupt application of the waveform after a preselected time period. The timing means may have selection means for selecting the time period. When the controller is a microprocessor based controller the timing means ma~~ be implemented by software programmed into the controller.
The apparatus may include input mans, e.g. in the form of a keypad connected to the controller, for inputting data into the controller, e.g. to select the time period provided by the timing means, a desired current level, and so on.
The apparatus may include display means for displaying magnitude of the output current of the waveform. During operation, the timing means may also be arranged to display the duration of operation of the apparatus via the display means .
The invention extends also to the use of a generated waveform comprising a sequence of pulses having a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, and an average output current of 0.1 to 10 ma, for controlling pain, said use comprising maintaining the pulse temporarily constant at said amplitude and feeding the pulse via a passive component so that the waveform thereafter decays exponentially from the temporary constant amplitude through zero volts to a negative value and remains negative for a sufficient time period to provide a negative DC offset to the waveform.
An embodiment of the invention is now described, by way of example, with reference to the accompanying diagrammatic drawings.
In the drawing, Figure 1 shows a schematic block diagram of a nerve stimulation apparatus in accordance with the invention;
Figure 2 shows a front elevation of a control panel of the apparatus of Figure 1;
Figure 3 shows a schematic circuit diagram of a display unit used in the apparatus of Figure 1;
Figure 4 shows a time domain representation of the waveform generated by the app~~ratus of Figure 1 (which is not to scale);
Figure 5 shows a schematic circuit diagram of a waveform generator used in the apparatus of Figure 1; and Figure 6 shows a schematic circuit diagram of a microprocessor based controller used to control the waveform generator of Figure 5.
Referring to Figure 1, reference numeral 10 generally indicates a nerve stimulation apparatus primarily intended for use in a method of treatment of and controlling pain in a human subject. The apparatus 10 includes a microprocessor based controller 12, a waveform generator 14, a display unit 16, and a power supply unit 18.
The waveform generator 14 generates a sequence of generally square pulses 20, the preferred form of which is shown in Figure 4. The waveform has been selected to simulate the so-called human nerve action potential which it is believed is a naturally occurring nerve impulse substantially similar to that shown in Figure 4. The pulses are emitted from output terminals 22, 24 of the waveform generator 14.
20 Generally, as shown in Figure 4, each pulse 20 has an amplitude 20.1 of about 40 volts to about 60 volts, preferably about 46 volts, with a negative DC off-set so that each pulse commences from a negative level of close to about -40 volts to -60 volts. A leading edge of the pulse rises steeply. Each pulse 20 has a positive peak 20.2 of about +10 mV to about +600 mV, preferably about 500 mV, and has a pulse width 20.3 of about 0.8 ms to about 1.2 ms, preferably about 1 ms. The repetition rate of the pulses 20 is between 150 Hz and 200 Hz, preferably about 150 Hz.
The pulses 20 have a constant current output which is adjustably variable between 0,01 mA and about 10 mA. After remaining at its peak at a substantially constant amplitude for about 0.2 ms, the pulse decays exponentially as shown.
The duration of the exponential decay is up to about 1 ms.
Referring to Figure 1, reference numeral 10 generally indicates a nerve stimulation apparatus primarily intended for use in a method of treatment of and controlling pain in a human subject. The apparatus 10 includes a microprocessor based controller 12, a waveform generator 14, a display unit 16, and a power supply unit 18.
The waveform generator 14 generates a sequence of generally square pulses 20, the preferred form of which is shown in Figure 4. The waveform has been selected to simulate the so-called human nerve action potential which it is believed is a naturally occurring nerve impulse substantially similar to that shown in Figure 4. The pulses are emitted from output terminals 22, 24 of the waveform generator 14.
20 Generally, as shown in Figure 4, each pulse 20 has an amplitude 20.1 of about 40 volts to about 60 volts, preferably about 46 volts, with a negative DC off-set so that each pulse commences from a negative level of close to about -40 volts to -60 volts. A leading edge of the pulse rises steeply. Each pulse 20 has a positive peak 20.2 of about +10 mV to about +600 mV, preferably about 500 mV, and has a pulse width 20.3 of about 0.8 ms to about 1.2 ms, preferably about 1 ms. The repetition rate of the pulses 20 is between 150 Hz and 200 Hz, preferably about 150 Hz.
The pulses 20 have a constant current output which is adjustably variable between 0,01 mA and about 10 mA. After remaining at its peak at a substantially constant amplitude for about 0.2 ms, the pulse decays exponentially as shown.
The duration of the exponential decay is up to about 1 ms.
The controller 12 controls the waveform generator 14 via a control bus 28 and system parameters are fed by an operator into the controller 12 via a keypad 26, the controller 12 thereby controlling the output parameters of the pulse 20. The output current is determined by the controller 12 which in turn controls the waveform generator 14 via the bus 28. The selected system parameters are then displayed by the display unit 16, as described below.
The output terminals 22, 24 of the waveform generator 14 are connected to electrode pads (not shown) which are operatively applied to the skin of a person and which are preferably in the form of plasma covered metal foil. An output current fed to the electrodes is also fed via lines 30 into the display unit 16 which has a liquid crystal display 32 for displaying the amplitude of the output current.
The power supply unit 18 is fed with a 9 V
regulated power signal via a supplementary power supply 19.
The supplementary power supply 19 has a step down transformer 19.1 which has a primary winding connected to a mains line and a secondary winding connected to a rectifier 19.2. An output of the rectifier 19.2 is fed via a 9 V voltage regulator 19.3 into the power supply unit 18.
The power supply unit 18 provides power to the display unit 16, the pulse generator 14, and the controller 12 via a power supply bus 34. The bus 34 is a bi directional bus thereby to enable the controller 12 to switch itself off after a preselected time period has lapsed. The time period is selected by entering via the keypad 26.
Referring to Figure 2, reference numeral 40 generally indicates a control panel on which various membrane switches 42 to 52 of the keypad 26 are mounted.
The switch 42 is an on/off switch for switching the apparatus 10 on and off and an LED 54 is illuminated when the apparatus 10 is switched on.
In use, the controller 12 is responsive to the switches 44 and 46 which, respectively, increase and decrease the output current upon actuation. The display 32 displays the output current from the waveform generator 14 thereby enabling an operator to monitor the current magnitude in use.
The switches 48 and 50 are used to select duration of operation of the apparatus. Switch 48 is a ten minute time period selector which, upon actuation, illuminates an LED 49 and provides a ten minute input signal to the controller 12. Likewise, upon actuation of the switch 50 a five minute timing signal is provided to the controller 12 and an LED 51 is illuminated. The switch 52 is a start/reset switch which, upon actuation, illuminates an LED
53 and provides a start/reset signal to the controller 12.
A bar graph display 56, formed by a plurality of stacked LED's, indicates the progression of the selected time by displaying the time remaining of the initial time period selected.
The waveform generator 14 has current regulating circuitry 60 (Figure 5) which regulates the output current of the waveform generator 14, and a voltage source 62 which is operatively connected in series with the current regulating circuitry 60. The series connection between the current regulating circuitry 60 and the voltage source 62 is provided in use by a patient's body.
The current regulating circuitry 60 includes a driver circuit 67, a Darlington transistor configuration 66 and current adjustment circuitry 68. A pulsed input signal is fed into the driver circuit 67 via a line 69 from the controller 12. The pulsed input signal is then fed into the transistor configuration 66 via a line 70 thereby regulating 2132~4~
_8_ the output waveform in sympathy with a level of the pulsed input signal.
The degree of negative off-set and the amplitude of the positive peak 20.2 relative to zero volts of the waveform shown in Figure 4 and emitted from the output terminals 22, 24 is consequent upon the current flowing in an emitter resistor 75 and the saturation voltage of the transistor configuration 66 which provides the negative off-set to the waveform. The degree of off-set and the level of the positive peak 20.2 varies depending upon the amount of current drawn by the load. The exponential decay of the pulse is provided by a capacitor 66.1 so that each pulse is fully discharged into the patient from the terminals 22, 24.
It will be noted that neither of the terminals 22, 24 is earthed so that the patient's body is in a floating series configuration with the apparatus.
A current control signal from the controller 12 is fed via a line 72 to a differential amplifier 74 of the current adjustment circuitry 68. An output from the differential amplifier 74 is fed via a line 78 to the transistor configuration 66 which controls the output current on the output terminals 22, 24.
The voltage source 62 includes a high frequency oscillator 73 implemented by sub-components of an integrated circuit 76 and associated circuitry, a coil 79 to which the high frequency output signal is applied, and a rectifier 81 connected to the coil 79, which rectifies the high frequency signal providing a rectified DC output voltage on line 80.
Smoothing capacitors 82 are provided to improve regulation.
The voltage source 62 includes a feedback circuit 77 which is connected intermediate the output of the voltage source 62 and the high frequency oscillator 73. The feedback circuit 77 increases the frequency of the oscillator 73 upon a decrease in the RMS value of the output voltage on line 80 thereby to maintain the RMS value of the _ g _ output voltage at a constant level. The feedback circuit 77 includes a feedback path 84 to feed back the output voltage on line 80 to a differential amplifier 86. An output from the differential amplifier 86 is fed into a flip-flop 83 and switching circuitry of the integrated circuit 76.
The waveform generator 14 also has power supply circuitry 88 which provides a 6 V regulated output to its various components.
Figure 6 shows a schematic circuit diagram of the controller 12 which controls the operation of the apparatus 10. The controller 12 comprises a microprocessor 90, typically an (OTP) 87C51 microprocessor, connected to the switches 42 to 52, a frequency to voltage converter 92, the display 56 for indicating the progression of time, a buzzer 94 and power cut-off circuitry 96. Timing means which is implemented by the microprocessor 90 and software loaded therein, disables the waveform generator 14 after a preselected time period via the bi-directional bus 34. The buzzer 94 is actuated upon the lapsing of the preselected time period thereby indicating that the time period selected has expired. The power cut-off circuitry 96 includes a relay 98 which is configured to interrupt power to the apparatus 10.
The switches 42 to 52 of the keypad 26 are connected to a first input/output port 90.1 of the microprocessor 90. Second and third input/output ports 90.2 and 90.3 are connected to and drive the display 56. The LEDs 49, 51 and 53 which respectively indicate the selection of the ten minute and five minute time period, and the start/reset condition correspond with those shown in Figure 2.
The microprocessor 90 generates the pulsed input signal at the port 90.3 which is then fed into the driver circuit 67 (Figure 5) via line 69. A port 90.4 is used to 2132.944 select a particular repetition rate of the pulsed input signal which, in turn, determines the repetition rate of the pulse 20. The controller 12 has a plurality of frequency selection means in the form of links or jumpers 71 which are connected to the port 90.4. Each particular jumper 71, when located in position, selects a predetermined frequency at which the pulse 20 is applied to the load via the output terminals 22, 24.
The microprocessor 90 provides a frequency dependent current control output signal on line 100, which is representative of a current selected by means of the current up switch 44 and the current down switch 46. A
higher frequency 100 is representative of a higher current and a lower frequency is representative of a lower current.
The current control signal on line 100 is fed into the frequency to voltage converter 92 which converts the signal to a voltage dependent signal on line 102. The voltage dependent signal on line 102 is then fed into the waveform generator 14 via line 72 (Figure 5). The controller 12 further includes a power supply 104 to provide a regulated 5 V output to the microprocessor 90.
Figure 3 shows a schematic circuit diagram of the display unit 16 used in the apparatus 10. The display unit 16 comprises the liquid crystal display 32, a display driver 106, typically an ICL 7106, and associated circuitry. As shown in Figure 5, a transistor 108 is connected in series between the output terminal 24 and the voltage source 62.
A second transistor 110, which has the same base current as the transistor 108, provides a signal on line 112 which is representative of the output current flowing from the apparatus 10. The signal on line 112 (Figure 5) is fed via line 114 (Figure 3) into the display unit 16.
The Applicant believes that the pulse 20 generated by the apparatus 10 is particularly effective in electrotherapy. When the apparatus 10 is operative and the electrodes connected to output terminals 22, 24 are secured -- ~132~4 ~
to the skin of a patient, current flows in the body of the patient via the electrodes. The Applicant believes that the current flow with the specific parameters selected has a beneficial effect on the neurons and biochemical functions of the body of the patient by stimulating nerve fibres or axons by lowering the membrane potentials of the axons. It is believed that axons inherently have the necessary energy to produce the so-called action potential and application of the Figure 4 waveform triggers the axons into action.
The Applicant believes that application of the pulsed waveform 20 of Figure 4 causes depolarization of the nerve fibres in the human body provided that the strength and duration of the pulsed waveform are of sufficient magnitude. Because the pulse shown in Figure 4 has a negative off-set relative to zero volts as shown rather than being a symmetrical pulse relative to zero volts or being a predominantly positive pulse relative to zero volts, the Applicant believes that this gives rise to a greater hypopolarizing effect on the nerve fibres and thus the pulse 20 generated by the apparatus 10 is particularly effective in electrotherapy.
It is believed that the low-frequency pulse 20 produces synchronous depolarization of the nerve fibres.
Thus, after the pulse 20 is applied to the skin of the human body via the electrodes, nerve fibres, not only close to the skin but also remote from the skin, gradually become depolarized. The effect of this depolarization is a reduction in pain and it relaxes the patient and improves the blood circulation of the patient.
The Applicant further believes that stimulation of thick afferent nerve fibres in the body has an inhibiting or blocking effect on the activity of thin afferent nerve fibres, and consequently pain perception is diminished. In addition to reducing pain by stimulation of the thick nerve fibres, normalization of the neuro-vegetative balance occurs. This means a damping of the orthosympathetic ~13z944 system, which is reflected in relaxation and improvement of the circulation of the blood. Stimulation of myelinate afferent nerve fibres in muscle or skin tissue causes orthosympathetic reflex discharges which are followed by a spontaneous post-excitation of the orthosympathetic reflex activity.
The output terminals 22, 24 of the waveform generator 14 are connected to electrode pads (not shown) which are operatively applied to the skin of a person and which are preferably in the form of plasma covered metal foil. An output current fed to the electrodes is also fed via lines 30 into the display unit 16 which has a liquid crystal display 32 for displaying the amplitude of the output current.
The power supply unit 18 is fed with a 9 V
regulated power signal via a supplementary power supply 19.
The supplementary power supply 19 has a step down transformer 19.1 which has a primary winding connected to a mains line and a secondary winding connected to a rectifier 19.2. An output of the rectifier 19.2 is fed via a 9 V voltage regulator 19.3 into the power supply unit 18.
The power supply unit 18 provides power to the display unit 16, the pulse generator 14, and the controller 12 via a power supply bus 34. The bus 34 is a bi directional bus thereby to enable the controller 12 to switch itself off after a preselected time period has lapsed. The time period is selected by entering via the keypad 26.
Referring to Figure 2, reference numeral 40 generally indicates a control panel on which various membrane switches 42 to 52 of the keypad 26 are mounted.
The switch 42 is an on/off switch for switching the apparatus 10 on and off and an LED 54 is illuminated when the apparatus 10 is switched on.
In use, the controller 12 is responsive to the switches 44 and 46 which, respectively, increase and decrease the output current upon actuation. The display 32 displays the output current from the waveform generator 14 thereby enabling an operator to monitor the current magnitude in use.
The switches 48 and 50 are used to select duration of operation of the apparatus. Switch 48 is a ten minute time period selector which, upon actuation, illuminates an LED 49 and provides a ten minute input signal to the controller 12. Likewise, upon actuation of the switch 50 a five minute timing signal is provided to the controller 12 and an LED 51 is illuminated. The switch 52 is a start/reset switch which, upon actuation, illuminates an LED
53 and provides a start/reset signal to the controller 12.
A bar graph display 56, formed by a plurality of stacked LED's, indicates the progression of the selected time by displaying the time remaining of the initial time period selected.
The waveform generator 14 has current regulating circuitry 60 (Figure 5) which regulates the output current of the waveform generator 14, and a voltage source 62 which is operatively connected in series with the current regulating circuitry 60. The series connection between the current regulating circuitry 60 and the voltage source 62 is provided in use by a patient's body.
The current regulating circuitry 60 includes a driver circuit 67, a Darlington transistor configuration 66 and current adjustment circuitry 68. A pulsed input signal is fed into the driver circuit 67 via a line 69 from the controller 12. The pulsed input signal is then fed into the transistor configuration 66 via a line 70 thereby regulating 2132~4~
_8_ the output waveform in sympathy with a level of the pulsed input signal.
The degree of negative off-set and the amplitude of the positive peak 20.2 relative to zero volts of the waveform shown in Figure 4 and emitted from the output terminals 22, 24 is consequent upon the current flowing in an emitter resistor 75 and the saturation voltage of the transistor configuration 66 which provides the negative off-set to the waveform. The degree of off-set and the level of the positive peak 20.2 varies depending upon the amount of current drawn by the load. The exponential decay of the pulse is provided by a capacitor 66.1 so that each pulse is fully discharged into the patient from the terminals 22, 24.
It will be noted that neither of the terminals 22, 24 is earthed so that the patient's body is in a floating series configuration with the apparatus.
A current control signal from the controller 12 is fed via a line 72 to a differential amplifier 74 of the current adjustment circuitry 68. An output from the differential amplifier 74 is fed via a line 78 to the transistor configuration 66 which controls the output current on the output terminals 22, 24.
The voltage source 62 includes a high frequency oscillator 73 implemented by sub-components of an integrated circuit 76 and associated circuitry, a coil 79 to which the high frequency output signal is applied, and a rectifier 81 connected to the coil 79, which rectifies the high frequency signal providing a rectified DC output voltage on line 80.
Smoothing capacitors 82 are provided to improve regulation.
The voltage source 62 includes a feedback circuit 77 which is connected intermediate the output of the voltage source 62 and the high frequency oscillator 73. The feedback circuit 77 increases the frequency of the oscillator 73 upon a decrease in the RMS value of the output voltage on line 80 thereby to maintain the RMS value of the _ g _ output voltage at a constant level. The feedback circuit 77 includes a feedback path 84 to feed back the output voltage on line 80 to a differential amplifier 86. An output from the differential amplifier 86 is fed into a flip-flop 83 and switching circuitry of the integrated circuit 76.
The waveform generator 14 also has power supply circuitry 88 which provides a 6 V regulated output to its various components.
Figure 6 shows a schematic circuit diagram of the controller 12 which controls the operation of the apparatus 10. The controller 12 comprises a microprocessor 90, typically an (OTP) 87C51 microprocessor, connected to the switches 42 to 52, a frequency to voltage converter 92, the display 56 for indicating the progression of time, a buzzer 94 and power cut-off circuitry 96. Timing means which is implemented by the microprocessor 90 and software loaded therein, disables the waveform generator 14 after a preselected time period via the bi-directional bus 34. The buzzer 94 is actuated upon the lapsing of the preselected time period thereby indicating that the time period selected has expired. The power cut-off circuitry 96 includes a relay 98 which is configured to interrupt power to the apparatus 10.
The switches 42 to 52 of the keypad 26 are connected to a first input/output port 90.1 of the microprocessor 90. Second and third input/output ports 90.2 and 90.3 are connected to and drive the display 56. The LEDs 49, 51 and 53 which respectively indicate the selection of the ten minute and five minute time period, and the start/reset condition correspond with those shown in Figure 2.
The microprocessor 90 generates the pulsed input signal at the port 90.3 which is then fed into the driver circuit 67 (Figure 5) via line 69. A port 90.4 is used to 2132.944 select a particular repetition rate of the pulsed input signal which, in turn, determines the repetition rate of the pulse 20. The controller 12 has a plurality of frequency selection means in the form of links or jumpers 71 which are connected to the port 90.4. Each particular jumper 71, when located in position, selects a predetermined frequency at which the pulse 20 is applied to the load via the output terminals 22, 24.
The microprocessor 90 provides a frequency dependent current control output signal on line 100, which is representative of a current selected by means of the current up switch 44 and the current down switch 46. A
higher frequency 100 is representative of a higher current and a lower frequency is representative of a lower current.
The current control signal on line 100 is fed into the frequency to voltage converter 92 which converts the signal to a voltage dependent signal on line 102. The voltage dependent signal on line 102 is then fed into the waveform generator 14 via line 72 (Figure 5). The controller 12 further includes a power supply 104 to provide a regulated 5 V output to the microprocessor 90.
Figure 3 shows a schematic circuit diagram of the display unit 16 used in the apparatus 10. The display unit 16 comprises the liquid crystal display 32, a display driver 106, typically an ICL 7106, and associated circuitry. As shown in Figure 5, a transistor 108 is connected in series between the output terminal 24 and the voltage source 62.
A second transistor 110, which has the same base current as the transistor 108, provides a signal on line 112 which is representative of the output current flowing from the apparatus 10. The signal on line 112 (Figure 5) is fed via line 114 (Figure 3) into the display unit 16.
The Applicant believes that the pulse 20 generated by the apparatus 10 is particularly effective in electrotherapy. When the apparatus 10 is operative and the electrodes connected to output terminals 22, 24 are secured -- ~132~4 ~
to the skin of a patient, current flows in the body of the patient via the electrodes. The Applicant believes that the current flow with the specific parameters selected has a beneficial effect on the neurons and biochemical functions of the body of the patient by stimulating nerve fibres or axons by lowering the membrane potentials of the axons. It is believed that axons inherently have the necessary energy to produce the so-called action potential and application of the Figure 4 waveform triggers the axons into action.
The Applicant believes that application of the pulsed waveform 20 of Figure 4 causes depolarization of the nerve fibres in the human body provided that the strength and duration of the pulsed waveform are of sufficient magnitude. Because the pulse shown in Figure 4 has a negative off-set relative to zero volts as shown rather than being a symmetrical pulse relative to zero volts or being a predominantly positive pulse relative to zero volts, the Applicant believes that this gives rise to a greater hypopolarizing effect on the nerve fibres and thus the pulse 20 generated by the apparatus 10 is particularly effective in electrotherapy.
It is believed that the low-frequency pulse 20 produces synchronous depolarization of the nerve fibres.
Thus, after the pulse 20 is applied to the skin of the human body via the electrodes, nerve fibres, not only close to the skin but also remote from the skin, gradually become depolarized. The effect of this depolarization is a reduction in pain and it relaxes the patient and improves the blood circulation of the patient.
The Applicant further believes that stimulation of thick afferent nerve fibres in the body has an inhibiting or blocking effect on the activity of thin afferent nerve fibres, and consequently pain perception is diminished. In addition to reducing pain by stimulation of the thick nerve fibres, normalization of the neuro-vegetative balance occurs. This means a damping of the orthosympathetic ~13z944 system, which is reflected in relaxation and improvement of the circulation of the blood. Stimulation of myelinate afferent nerve fibres in muscle or skin tissue causes orthosympathetic reflex discharges which are followed by a spontaneous post-excitation of the orthosympathetic reflex activity.
Claims (7)
1. A nerve stimulator apparatus which includes a waveform generator for generating a waveform comprising a sequence of pulses which are operatively fed to a first output terminal and a second output terminal of the apparatus, the waveform generator comprising:
current regulating means connected to the first output terminal and operable to regulate an output current of the waveform generator;
a voltage source connected to the second output terminal so that a load connectable to the first and second output terminals provides a series connection between the current regulating means and the voltage source;
a passive component connected across the first and the second output terminals to provide an exponential decay of each pulse; and a controller connected to the current regulating means and to the voltage source, said controller being operable to control the current regulating means and the voltage source so that the pulses generated by the waveform generator have a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, an amplitude of between 40 and 60 Volts, and an average output current of 0.01 to 10 mA.
current regulating means connected to the first output terminal and operable to regulate an output current of the waveform generator;
a voltage source connected to the second output terminal so that a load connectable to the first and second output terminals provides a series connection between the current regulating means and the voltage source;
a passive component connected across the first and the second output terminals to provide an exponential decay of each pulse; and a controller connected to the current regulating means and to the voltage source, said controller being operable to control the current regulating means and the voltage source so that the pulses generated by the waveform generator have a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, an amplitude of between 40 and 60 Volts, and an average output current of 0.01 to 10 mA.
2. An apparatus as claimed in claim 1, in which the voltage source has voltage off set means operable to adjust a negative DC off set of the waveform so that each pulse has a positive peak of 10 to 600 mV and whereafter said pulse decays exponentially from a positive value to a negative value.
3. An apparatus as claimed in claim 1, in which the controller includes a microprocessor having software for controlling the waveform generator, and a frequency to voltage converter connected to the microprocessor and operable to convert a frequency dependent signal, which is sourced from the microprocessor and representative of a desired output current, to a voltage dependent signal which is fed into the current regulating means thereby to control the output current of the apparatus.
4. An apparatus as claimed in claim 1, in which the current regulating means comprises a constant current source.
5. An apparatus as claimed in claim 1, in which the voltage source comprises a constant voltage source.
6. An apparatus as claimed in claim 1, wherein said passive component comprises a capacitor.
7. The use of a generated waveform comprising a sequence of pulses having a repetition rate of 150 to 200 Hz, a pulse width of 0.8 to 1.2 ms, and an average output current of 0.1 to 10 ma, for controlling pain, said use comprising maintaining the pulse temporarily constant at said amplitude and feeding the pulse via a passive component so that the waveform thereafter decays exponentially from the temporary constant amplitude through zero volts to a negative value and remains negative for a sufficient time period to provide a negative DC offset to the waveform.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA93/7235 | 1993-09-29 | ||
| ZA937235 | 1993-09-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2132944A1 CA2132944A1 (en) | 1995-03-30 |
| CA2132944C true CA2132944C (en) | 2001-05-08 |
Family
ID=25583276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002132944A Expired - Fee Related CA2132944C (en) | 1993-09-29 | 1994-09-26 | Nerve stimulation apparatus and method |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5628768A (en) |
| EP (1) | EP0645162B1 (en) |
| AT (1) | ATE191353T1 (en) |
| AU (1) | AU676368B2 (en) |
| BR (1) | BR9403914A (en) |
| CA (1) | CA2132944C (en) |
| DE (1) | DE69423836T2 (en) |
| DK (1) | DK0645162T3 (en) |
| ES (1) | ES2144036T3 (en) |
| GR (1) | GR3033805T3 (en) |
| HK (1) | HK1005126A1 (en) |
| NZ (1) | NZ264554A (en) |
| PT (1) | PT645162E (en) |
| SG (1) | SG46990A1 (en) |
| UY (1) | UY23837A1 (en) |
| ZA (1) | ZA947493B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006106A1 (en) * | 1997-07-31 | 1999-02-11 | Neuro Stim 2000 (Proprietary) Limited | Apparatus for electrical stimulation of a body |
| US6159163A (en) * | 1998-05-07 | 2000-12-12 | Cedars-Sinai Medical Center | System for attenuating pain during bone marrow aspiration and method |
| DE19904383C2 (en) * | 1999-02-03 | 2002-06-13 | Gerd Rudolphi | Method for stimulating a reflex zone assigned to a pathology area and device for carrying out the method |
| US6704603B1 (en) * | 2000-05-16 | 2004-03-09 | Lockheed Martin Corporation | Adaptive stimulator for relief of symptoms of neurological disorders |
| US6512955B1 (en) | 2000-08-07 | 2003-01-28 | Mcenany Thomas J. | Electrical apparatus for therapeutic treatment |
| WO2003070316A2 (en) * | 2002-02-19 | 2003-08-28 | Austria Wirtschaftsservice Gesellschaft Mit Beschänkter Haftung | Arrangement for receiving electrical signals from living cells and for stimulation |
| US7089057B2 (en) * | 2002-04-26 | 2006-08-08 | Medtronic, Inc. | Detection of possible failure of capacitive elements in an implantable medical device |
| US20040015212A1 (en) * | 2002-05-31 | 2004-01-22 | Empi, Corp. | Electrotherapy stimulation device having electrode peel off detection capabilities |
| US7228179B2 (en) * | 2002-07-26 | 2007-06-05 | Advanced Neuromodulation Systems, Inc. | Method and apparatus for providing complex tissue stimulation patterns |
| DE102005003735B4 (en) | 2005-01-26 | 2008-04-03 | Cerbomed Gmbh | Device for transcutaneous stimulation of a nerve of the human body |
| US8694118B2 (en) * | 2005-10-28 | 2014-04-08 | Cyberonics, Inc. | Variable output ramping for an implantable medical device |
| DE102006033623B4 (en) * | 2006-07-18 | 2010-04-08 | Cerbomed Gmbh | System for transcutaneous stimulation of a nerve of the human body |
| US10057543B2 (en) * | 2008-10-31 | 2018-08-21 | Arris Enterprises Llc | Digital video recorder having live-off-disk buffer for receiving missing portions of buffered events |
| US8275461B2 (en) * | 2010-12-02 | 2012-09-25 | Xavant Technology | Pain relieving waveform system and method |
| DE102011009528B4 (en) | 2011-01-26 | 2013-09-05 | Cerbomed Gmbh | Device for transcutaneous stimulation of a nerve of the human body |
| EP3852618A1 (en) * | 2018-09-21 | 2021-07-28 | Battelle Memorial Institute | Non-invasive and selective bioelectronic control of blood pressure |
| DE102022002797A1 (en) | 2022-08-02 | 2024-02-08 | Rajan Govinda | Dosing device for adding at least one pharmaceutically active substance to a breathing gas provided extracorporeally, device for providing a breathing gas with such a dosing device and method |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3160159A (en) * | 1960-01-04 | 1964-12-08 | Hoody Jusha Borisovich | Device for inducing sleep |
| DE2158132C2 (en) * | 1971-11-24 | 1974-01-03 | Robert Bosch Elektronik Gmbh, 1000 Berlin Und 7000 Stuttgart | Stimulation current diagnostic device |
| US3989051A (en) * | 1974-09-30 | 1976-11-02 | Valentin Matveevich Nozhnikov | Apparatus for current pulse action upon central nervous system |
| DE2507783A1 (en) * | 1975-02-22 | 1976-09-02 | Grauvogel Kurt | PULSE GENERATOR FOR BIOELECTRIC DEVICES FOR THE APPLICATION OF ELECTRIC PULSES ON LIVING ORGANISMS |
| US4102347A (en) * | 1976-12-03 | 1978-07-25 | Yukl Tex N | Electronic pain control system |
| JPS5810109B2 (en) * | 1979-06-15 | 1983-02-24 | 松下電工株式会社 | low frequency treatment device |
| GB2052991B (en) * | 1979-07-12 | 1983-04-27 | Sp Ni Opyt Konstrukt Bjuro Mar | Apparatus for electrical stimulation of mammae |
| US4340063A (en) * | 1980-01-02 | 1982-07-20 | Empi, Inc. | Stimulation device |
| YU40782B (en) * | 1980-10-23 | 1986-06-30 | Gorenje | Control circuit of a functional and therapeutic stimulator |
| FR2502015B1 (en) * | 1981-03-17 | 1985-09-06 | Benoit Gino | METHOD AND APPARATUS FOR SKIN ENHANCEMENT FOR FIRMING THEREOF, REMOVAL OF WRINKLES AND ELIMINATION OF CELLULITE |
| GB2099705A (en) * | 1981-06-04 | 1982-12-15 | Dow Corning | Pulse generator for pain blocking bandage |
| US4459988A (en) * | 1982-02-22 | 1984-07-17 | Biolectron, Inc. | Electrical stimulating apparatus |
| AU1573183A (en) * | 1982-06-18 | 1983-12-22 | Biostim Inc. | Biological electrical stimulators |
| US4539993A (en) * | 1982-11-18 | 1985-09-10 | Medtronic, Inc. | Fail-safe muscle stimulator device |
| US4528984A (en) * | 1983-04-25 | 1985-07-16 | Empi, Inc. | Autoprogrammable functional electrical stimulation apparatus and method |
| US4622973A (en) * | 1984-06-15 | 1986-11-18 | Empi, Inc. | Programmable functional electrical stimulation system |
| US4769881A (en) * | 1986-09-02 | 1988-09-13 | Pedigo Irby R | High precision tens apparatus and method of use |
| US5117826A (en) * | 1987-02-02 | 1992-06-02 | Staodyn, Inc. | Combined nerve fiber and body tissue stimulation apparatus and method |
| JPH064096B2 (en) * | 1987-03-25 | 1994-01-19 | 株式会社アドバンス | Skin adhesive type low frequency treatment device |
| DE3811140A1 (en) * | 1988-03-31 | 1989-10-12 | Henneberg & Brunner Entwicklun | ELECTRICITY DEVICE |
| DE3813013A1 (en) * | 1988-04-19 | 1989-11-02 | Henneberg & Brunner Entwicklun | IRRITATION DEVICE |
| CH679331A5 (en) * | 1989-08-11 | 1992-01-31 | Atlantis Energie Ag | |
| GB8924559D0 (en) | 1989-11-01 | 1989-12-20 | Capel Ifor D | Method for transcranial electrotherapy |
| JPH0659320B2 (en) * | 1989-11-20 | 1994-08-10 | 三洋電機株式会社 | Wireless low frequency therapy device |
| US5184617A (en) * | 1990-06-05 | 1993-02-09 | Staodyn, Inc. | Output pulse compensation for therapeutic-type electronic devices |
| US5342410A (en) * | 1990-10-05 | 1994-08-30 | Eric Braverman | Apparatus and method for increasing the amplitude of P300 waves in the human brain |
| US5431625A (en) * | 1991-02-01 | 1995-07-11 | Empi, Inc. | Iontophoresis electronic device having a ramped output current |
| US5222494A (en) * | 1991-07-31 | 1993-06-29 | Cyberonics, Inc. | Implantable tissue stimulator output stabilization system |
| US5273033A (en) * | 1991-09-19 | 1993-12-28 | Murray Electronics Associates Limited Partnership | Electrical stimulation for treatment of osteoarthritis |
| FR2684872B1 (en) * | 1991-12-11 | 1998-04-10 | Limoge Cie Courants | ELECTROSTIMULATION DEVICE BY HIGH FREQUENCY CURRENTS MODULATED BY LOW FREQUENCY CURRENTS. |
| US5397338A (en) * | 1993-03-29 | 1995-03-14 | Maven Labs, Inc. | Electrotherapy device |
| US5514165A (en) * | 1993-12-23 | 1996-05-07 | Jace Systems, Inc. | Combined high voltage pulsed current and neuromuscular stimulation electrotherapy device |
| US5540734A (en) * | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
-
1994
- 1994-09-26 ZA ZA947493A patent/ZA947493B/en unknown
- 1994-09-26 CA CA002132944A patent/CA2132944C/en not_active Expired - Fee Related
- 1994-09-27 NZ NZ264554A patent/NZ264554A/en unknown
- 1994-09-28 EP EP94307072A patent/EP0645162B1/en not_active Expired - Lifetime
- 1994-09-28 US US08/314,159 patent/US5628768A/en not_active Expired - Fee Related
- 1994-09-28 ES ES94307072T patent/ES2144036T3/en not_active Expired - Lifetime
- 1994-09-28 AU AU74293/94A patent/AU676368B2/en not_active Ceased
- 1994-09-28 DK DK94307072T patent/DK0645162T3/en active
- 1994-09-28 SG SG1996001108A patent/SG46990A1/en unknown
- 1994-09-28 DE DE69423836T patent/DE69423836T2/en not_active Expired - Fee Related
- 1994-09-28 BR BR949403914A patent/BR9403914A/en not_active IP Right Cessation
- 1994-09-28 AT AT94307072T patent/ATE191353T1/en not_active IP Right Cessation
- 1994-09-28 PT PT94307072T patent/PT645162E/en unknown
- 1994-09-29 UY UY23837A patent/UY23837A1/en not_active IP Right Cessation
-
1998
- 1998-05-19 HK HK98104318A patent/HK1005126A1/en not_active IP Right Cessation
-
2000
- 2000-06-28 GR GR20000401504T patent/GR3033805T3/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9403914A (en) | 1995-06-13 |
| AU676368B2 (en) | 1997-03-06 |
| ES2144036T3 (en) | 2000-06-01 |
| ZA947493B (en) | 1995-05-29 |
| CA2132944A1 (en) | 1995-03-30 |
| SG46990A1 (en) | 1998-03-20 |
| GR3033805T3 (en) | 2000-10-31 |
| US5628768A (en) | 1997-05-13 |
| EP0645162A1 (en) | 1995-03-29 |
| DE69423836T2 (en) | 2000-08-03 |
| UY23837A1 (en) | 1995-02-21 |
| AU7429394A (en) | 1995-04-13 |
| EP0645162B1 (en) | 2000-04-05 |
| DK0645162T3 (en) | 2000-09-04 |
| PT645162E (en) | 2000-07-31 |
| DE69423836D1 (en) | 2000-05-11 |
| NZ264554A (en) | 1996-11-26 |
| HK1005126A1 (en) | 1998-12-24 |
| ATE191353T1 (en) | 2000-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2132944C (en) | Nerve stimulation apparatus and method | |
| US4431002A (en) | Modulated deep afferent stimulator | |
| US4580570A (en) | Electrical therapeutic apparatus | |
| US5063929A (en) | Electronic stimulating device having timed treatment of varying intensity and method therefor | |
| US4340063A (en) | Stimulation device | |
| US4232680A (en) | Apparatus and method for transcutaneous electrotherapy nerve stimulator | |
| US4177819A (en) | Muscle stimulating apparatus | |
| CA1335302C (en) | Microprocessor controlled electronic stimulating device having biphasic pulse output | |
| KR102566842B1 (en) | Electrostimulation related devices and methods | |
| EP1326679B1 (en) | System for varying characteristics of electrical therapy | |
| US4392496A (en) | Neuromuscular stimulator | |
| US5514165A (en) | Combined high voltage pulsed current and neuromuscular stimulation electrotherapy device | |
| US5964789A (en) | Transcutaneous electric muscle/nerve controller/feedback unit | |
| US6249706B1 (en) | Electrotherapy system | |
| US5350415A (en) | Device for trophic stimulation of muscles | |
| US10518088B2 (en) | Method of adaptive electric action on a living organism (variants) | |
| EP0524321A1 (en) | Output pulse compensation for therapeutic-type electronic devices | |
| DE3321839A1 (en) | BIOLOGICAL ELECTRIC STIMULATOR | |
| EP0601545A2 (en) | Improved electromagnetic bioresponse by selective spectral suppression, in pulsed field stimulation | |
| US4453548A (en) | Method of improving sensory tolerance with modulated nerve stimulator | |
| JPH03505051A (en) | Method and device for generating electrical pulses for biological stimulation | |
| KR20020093472A (en) | Method of forming therapy protocol for use in a magnetic urinary incontinence therapy system and apparatus thereof | |
| US4815475A (en) | Modulation system for evoked response stimulation and method | |
| CN108261607A (en) | A kind of functional transcutaneous electrical stimulation device for motion function regulation and control | |
| US4690146A (en) | Neuromuscular stimulating apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |